Search research articles
Contact Us
Filters
Showing results (1481-1490 of 1,605) with videos related to
Page
of 161
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 28, 2019
Outcomes of Older Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer Treated With a CDK4/6 Inhibitor and an Aromatase Inhibitor: An FDA Pooled Analysis
Lynn J Howie, Harpreet Singh, Erik Bloomquist, et al.
The American Journal of Cardiology
|
February 26, 2020
Novel Anatomic Predictors of New Persistent Left Bundle Branch Block After Evolut Transcatheter Aortic Valve Implantation
Syed Zaid, Aditya Sengupta, Kimberly Okoli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 23, 2025
Osimertinib Plus Savolitinib in Patients With EGFR-Mutated Advanced NSCLC With MET Alterations After First-Line Osimertinib: Clinical Outcomes, Safety, and Biomarker Analysis: A Brief Report
Xiuning Le, Christina Baik, Byoung Chul Cho, et al.
Clinical Psychological Science : a Journal of the Association for Psychological Science
|
June 5, 2026
Multimodal assessments of therapist characteristics are largely unrelated to patient outcomes: A preregistered analysis
Simon B Goldberg, Scott A Baldwin, Anthony W P Flynn, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 27, 2012
Common variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/2), adiponectin concentrations, and diabetes incidence in the Diabetes Prevention Program
K J Mather, C A Christophi, K A Jablonski, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1983
Expression of bacterial genes in plant cells
R T Fraley, S G Rogers, R B Horsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2020
FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma
Sandra J Casak, Martha Donoghue, Lola Fashoyin-Aje, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 5, 2023
Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in Programmed Cell Death-(Ligand)1-Monotherapy Pretreated, Advanced NSCLC: Results From a Phase 1b Clinical Trial
Edward B Garon, Alexander I Spira, Sarah B Goldberg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 27, 2026
Osimertinib plus selumetinib in patients with EGFR-mutated advanced NSCLC with BRAF alterations post-progression on first-line osimertinib: ORCHARD
Zofia Piotrowska, Sarah B Goldberg, Jonathan W Goldman, et al.
Infection and Immunity
|
April 22, 2003
Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T
J Wei, M B Goldberg, V Burland, et al.
Page
of 161
Search research articles
Search
Showing results (1481-1490 of 1,605) with videos related to
Sort By:
Page
of 161
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 28, 2019
Outcomes of Older Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer Treated With a CDK4/6 Inhibitor and an Aromatase Inhibitor: An FDA Pooled Analysis
Lynn J Howie, Harpreet Singh, Erik Bloomquist, et al.
The American Journal of Cardiology
|
February 26, 2020
Novel Anatomic Predictors of New Persistent Left Bundle Branch Block After Evolut Transcatheter Aortic Valve Implantation
Syed Zaid, Aditya Sengupta, Kimberly Okoli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 23, 2025
Osimertinib Plus Savolitinib in Patients With EGFR-Mutated Advanced NSCLC With MET Alterations After First-Line Osimertinib: Clinical Outcomes, Safety, and Biomarker Analysis: A Brief Report
Xiuning Le, Christina Baik, Byoung Chul Cho, et al.
Clinical Psychological Science : a Journal of the Association for Psychological Science
|
June 5, 2026
Multimodal assessments of therapist characteristics are largely unrelated to patient outcomes: A preregistered analysis
Simon B Goldberg, Scott A Baldwin, Anthony W P Flynn, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 27, 2012
Common variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/2), adiponectin concentrations, and diabetes incidence in the Diabetes Prevention Program
K J Mather, C A Christophi, K A Jablonski, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1983
Expression of bacterial genes in plant cells
R T Fraley, S G Rogers, R B Horsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2020
FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma
Sandra J Casak, Martha Donoghue, Lola Fashoyin-Aje, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 5, 2023
Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in Programmed Cell Death-(Ligand)1-Monotherapy Pretreated, Advanced NSCLC: Results From a Phase 1b Clinical Trial
Edward B Garon, Alexander I Spira, Sarah B Goldberg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 27, 2026
Osimertinib plus selumetinib in patients with EGFR-mutated advanced NSCLC with BRAF alterations post-progression on first-line osimertinib: ORCHARD
Zofia Piotrowska, Sarah B Goldberg, Jonathan W Goldman, et al.
Infection and Immunity
|
April 22, 2003
Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T
J Wei, M B Goldberg, V Burland, et al.
Page
of 161